Back to Journals » OncoTargets and Therapy » Volume 11
Review
Early and late outcomes of bevacizumab plus chemotherapy versus chemotherapy alone as a neoadjuvant treatment in HER2-negative nonmetastatic breast cancer: a meta-analysis of randomized controlled trials
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
7,638 | Dovepress* | 7,283+ | 874 | 8,157 | |
PubMed Central* | 355 | 174 | 529 | ||
Totals | 7,638 | 1,048 | 8,686 | ||
*Since 12 December 2018 |
View citations on PubMed Central and Google Scholar